| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.61e-09 | 303 | 6 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.02e-07 | 562 | 6 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 3.75e-06 | 1160 | 6 | 5 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 8.12e-06 | 1356 | 6 | 5 | GO:0060090 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.37e-04 | 61 | 6 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.28e-03 | 187 | 6 | 2 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.17e-03 | 417 | 6 | 2 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.18e-02 | 582 | 6 | 2 | GO:0140297 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.86e-02 | 739 | 6 | 2 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.93e-02 | 753 | 6 | 2 | GO:0008134 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 8.93e-05 | 51 | 6 | 2 | GO:1902459 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 8.93e-05 | 51 | 6 | 2 | GO:0030521 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 2.10e-04 | 78 | 6 | 2 | GO:2000036 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.11e-04 | 95 | 6 | 2 | GO:2000781 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 4.91e-04 | 614 | 6 | 3 | GO:0010720 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 6.36e-04 | 136 | 6 | 2 | GO:0030518 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 7.03e-04 | 143 | 6 | 2 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 7.13e-04 | 144 | 6 | 2 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 7.33e-04 | 146 | 6 | 2 | GO:2000779 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 8.25e-04 | 155 | 6 | 2 | GO:0043401 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 9.01e-04 | 162 | 6 | 2 | GO:0045621 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.40e-03 | 202 | 6 | 2 | GO:0141193 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.48e-03 | 896 | 6 | 3 | GO:0006325 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.74e-03 | 226 | 6 | 2 | GO:0045580 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.87e-03 | 234 | 6 | 2 | GO:0006282 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.91e-03 | 237 | 6 | 2 | GO:0019827 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.94e-03 | 239 | 6 | 2 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.99e-03 | 242 | 6 | 2 | GO:1902107 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.99e-03 | 242 | 6 | 2 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.99e-03 | 242 | 6 | 2 | GO:1903708 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.03e-03 | 244 | 6 | 2 | GO:0009755 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 2.03e-03 | 999 | 6 | 3 | GO:0071824 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 2.40e-03 | 266 | 6 | 2 | GO:0045619 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 2.64e-03 | 1095 | 6 | 3 | GO:0060284 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 2.85e-03 | 290 | 6 | 2 | GO:0050870 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 2.98e-03 | 1141 | 6 | 3 | GO:0045597 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 3.39e-03 | 317 | 6 | 2 | GO:1903039 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 3.54e-03 | 324 | 6 | 2 | GO:0006302 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 3.73e-03 | 333 | 6 | 2 | GO:0051054 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 4.86e-03 | 381 | 6 | 2 | GO:0048545 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 4.88e-03 | 382 | 6 | 2 | GO:0030217 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 4.96e-03 | 385 | 6 | 2 | GO:0051251 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 5.06e-03 | 389 | 6 | 2 | GO:0022409 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 5.23e-03 | 1390 | 6 | 3 | GO:0045944 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 5.77e-03 | 416 | 6 | 2 | GO:0030522 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 5.96e-03 | 423 | 6 | 2 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 6.12e-03 | 429 | 6 | 2 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 6.63e-03 | 447 | 6 | 2 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 6.69e-03 | 449 | 6 | 2 | GO:0050867 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 6.96e-03 | 458 | 6 | 2 | GO:0050863 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 7.80e-03 | 486 | 6 | 2 | GO:0007159 | |
| GeneOntologyBiologicalProcess | forebrain development | 7.90e-03 | 489 | 6 | 2 | GO:0030900 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 9.47e-03 | 537 | 6 | 2 | GO:0030098 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 9.57e-03 | 540 | 6 | 2 | GO:1903706 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.04e-02 | 564 | 6 | 2 | GO:0051052 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 1.09e-02 | 579 | 6 | 2 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.10e-02 | 580 | 6 | 2 | GO:0022407 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 1.16e-02 | 598 | 6 | 2 | GO:0080135 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 1.19e-02 | 605 | 6 | 2 | GO:0071407 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 1.23e-02 | 614 | 6 | 2 | GO:0051249 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.86e-06 | 96 | 6 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 4.53e-06 | 129 | 6 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | npBAF complex | 6.24e-06 | 14 | 6 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 8.22e-06 | 16 | 6 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.98e-05 | 30 | 6 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 2.53e-04 | 1377 | 6 | 4 | GO:0140513 | |
| GeneOntologyCellularComponent | chromatin | 3.34e-04 | 1480 | 6 | 4 | GO:0000785 | |
| MousePheno | abnormal embryonic growth/weight/body size | 3.75e-05 | 1295 | 6 | 5 | MP:0002088 | |
| MousePheno | abnormal prenatal growth/weight/body size | 7.55e-05 | 1493 | 6 | 5 | MP:0004196 | |
| MousePheno | abnormal extraembryonic tissue morphology | 2.39e-04 | 908 | 6 | 4 | MP:0002086 | |
| MousePheno | abnormal embryonic tissue morphology | 5.32e-04 | 1116 | 6 | 4 | MP:0002085 | |
| MousePheno | abnormal gastrulation | 6.96e-04 | 469 | 6 | 3 | MP:0001695 | |
| MousePheno | pale yolk sac | 9.02e-04 | 110 | 6 | 2 | MP:0001722 | |
| MousePheno | failure to gastrulate | 1.05e-03 | 119 | 6 | 2 | MP:0001696 | |
| MousePheno | abnormal developmental patterning | 1.27e-03 | 577 | 6 | 3 | MP:0002084 | |
| Domain | SS18_fam | 2.58e-07 | 3 | 6 | 2 | IPR007726 | |
| Domain | SSXT | 2.58e-07 | 3 | 6 | 2 | PF05030 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 4.89e-07 | 42 | 6 | 3 | M48237 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 5.84e-06 | 95 | 6 | 3 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 6.22e-06 | 97 | 6 | 3 | M48262 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.76e-05 | 137 | 6 | 3 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.96e-05 | 142 | 6 | 3 | M48257 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.11e-04 | 254 | 6 | 3 | M27131 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.65e-02 | 1432 | 6 | 3 | M509 | |
| Pubmed | 1.30e-09 | 15 | 6 | 3 | 23785148 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 5.05e-09 | 23 | 6 | 3 | 30962207 | |
| Pubmed | Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci. | 2.48e-08 | 2 | 6 | 2 | 16484776 | |
| Pubmed | 7.44e-08 | 3 | 6 | 2 | 16926188 | ||
| Pubmed | 7.44e-08 | 3 | 6 | 2 | 11435705 | ||
| Pubmed | 1.24e-07 | 65 | 6 | 3 | 26655900 | ||
| Pubmed | 4.17e-07 | 453 | 6 | 4 | 29656893 | ||
| Pubmed | 5.21e-07 | 7 | 6 | 2 | 23540691 | ||
| Pubmed | 1.64e-06 | 12 | 6 | 2 | 11734557 | ||
| Pubmed | 1.79e-06 | 157 | 6 | 3 | 30186101 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 2.25e-06 | 14 | 6 | 2 | 36289231 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 8.08e-06 | 954 | 6 | 4 | 36373674 | |
| Pubmed | 8.69e-06 | 27 | 6 | 2 | 29374058 | ||
| Pubmed | 1.00e-05 | 29 | 6 | 2 | 19279220 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.99e-05 | 351 | 6 | 3 | 38297188 | |
| Pubmed | 3.43e-05 | 421 | 6 | 3 | 34650049 | ||
| Pubmed | 3.98e-05 | 1429 | 6 | 4 | 35140242 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.38e-05 | 457 | 6 | 3 | 32344865 | |
| Pubmed | 4.52e-05 | 61 | 6 | 2 | 20305087 | ||
| Pubmed | 9.43e-05 | 88 | 6 | 2 | 26318153 | ||
| Pubmed | 1.18e-04 | 638 | 6 | 3 | 31182584 | ||
| Interaction | SS18 interactions | 5.06e-09 | 88 | 6 | 4 | int:SS18 | |
| Interaction | PHF10 interactions | 3.22e-08 | 139 | 6 | 4 | int:PHF10 | |
| Interaction | ARID2 interactions | 4.73e-08 | 153 | 6 | 4 | int:ARID2 | |
| Interaction | PBRM1 interactions | 3.86e-07 | 258 | 6 | 4 | int:PBRM1 | |
| Interaction | ARID1A interactions | 5.05e-07 | 276 | 6 | 4 | int:ARID1A | |
| Interaction | FLI1 interactions | 5.51e-07 | 62 | 6 | 3 | int:FLI1 | |
| Interaction | BICRA interactions | 6.97e-07 | 67 | 6 | 3 | int:BICRA | |
| Interaction | SP7 interactions | 7.44e-07 | 304 | 6 | 4 | int:SP7 | |
| Interaction | ETV4 interactions | 7.63e-07 | 69 | 6 | 3 | int:ETV4 | |
| Interaction | SMARCD1 interactions | 1.29e-06 | 349 | 6 | 4 | int:SMARCD1 | |
| Interaction | STK11IP interactions | 1.34e-06 | 83 | 6 | 3 | int:STK11IP | |
| Interaction | SMARCC2 interactions | 1.35e-06 | 353 | 6 | 4 | int:SMARCC2 | |
| Interaction | SMARCB1 interactions | 1.53e-06 | 364 | 6 | 4 | int:SMARCB1 | |
| Interaction | SMARCC1 interactions | 1.89e-06 | 384 | 6 | 4 | int:SMARCC1 | |
| Interaction | DPF3 interactions | 2.01e-06 | 95 | 6 | 3 | int:DPF3 | |
| Interaction | DPF1 interactions | 2.01e-06 | 95 | 6 | 3 | int:DPF1 | |
| Interaction | BCL7B interactions | 2.01e-06 | 95 | 6 | 3 | int:BCL7B | |
| Interaction | SS18L1 interactions | 2.21e-06 | 98 | 6 | 3 | int:SS18L1 | |
| Interaction | SMARCD3 interactions | 2.88e-06 | 107 | 6 | 3 | int:SMARCD3 | |
| Interaction | BCL7C interactions | 3.58e-06 | 115 | 6 | 3 | int:BCL7C | |
| Interaction | TBXT interactions | 3.67e-06 | 116 | 6 | 3 | int:TBXT | |
| Interaction | BRD9 interactions | 3.77e-06 | 117 | 6 | 3 | int:BRD9 | |
| Interaction | SMARCA4 interactions | 3.94e-06 | 462 | 6 | 4 | int:SMARCA4 | |
| Interaction | DDIT3 interactions | 4.06e-06 | 120 | 6 | 3 | int:DDIT3 | |
| Interaction | ETS1 interactions | 4.17e-06 | 121 | 6 | 3 | int:ETS1 | |
| Interaction | BCL7A interactions | 4.38e-06 | 123 | 6 | 3 | int:BCL7A | |
| Interaction | PAX7 interactions | 4.49e-06 | 124 | 6 | 3 | int:PAX7 | |
| Interaction | TP53BP1 interactions | 6.96e-06 | 533 | 6 | 4 | int:TP53BP1 | |
| Interaction | ELF5 interactions | 7.48e-06 | 147 | 6 | 3 | int:ELF5 | |
| Interaction | MYCN interactions | 8.25e-06 | 1373 | 6 | 5 | int:MYCN | |
| Interaction | ARID1B interactions | 1.31e-05 | 177 | 6 | 3 | int:ARID1B | |
| Interaction | SMARCD2 interactions | 1.44e-05 | 183 | 6 | 3 | int:SMARCD2 | |
| Interaction | MYOD1 interactions | 1.72e-05 | 194 | 6 | 3 | int:MYOD1 | |
| Interaction | TCF7 interactions | 1.86e-05 | 23 | 6 | 2 | int:TCF7 | |
| Interaction | ACTC1 interactions | 1.98e-05 | 694 | 6 | 4 | int:ACTC1 | |
| Interaction | ERG interactions | 2.61e-05 | 223 | 6 | 3 | int:ERG | |
| Interaction | CRX interactions | 3.85e-05 | 254 | 6 | 3 | int:CRX | |
| Interaction | HDAC2 interactions | 4.72e-05 | 865 | 6 | 4 | int:HDAC2 | |
| Interaction | HNF4A interactions | 4.88e-05 | 275 | 6 | 3 | int:HNF4A | |
| Interaction | SMARCE1 interactions | 5.54e-05 | 287 | 6 | 3 | int:SMARCE1 | |
| Interaction | ACTL6A interactions | 5.65e-05 | 289 | 6 | 3 | int:ACTL6A | |
| Interaction | FOS interactions | 7.10e-05 | 312 | 6 | 3 | int:FOS | |
| Interaction | MAPK1IP1L interactions | 7.27e-05 | 45 | 6 | 2 | int:MAPK1IP1L | |
| Interaction | SMC5 interactions | 8.34e-05 | 1000 | 6 | 4 | int:SMC5 | |
| Interaction | SF3B4 interactions | 9.33e-05 | 342 | 6 | 3 | int:SF3B4 | |
| Interaction | SMARCA2 interactions | 9.66e-05 | 346 | 6 | 3 | int:SMARCA2 | |
| Interaction | DPF2 interactions | 9.91e-05 | 349 | 6 | 3 | int:DPF2 | |
| Interaction | GATA4 interactions | 1.61e-04 | 411 | 6 | 3 | int:GATA4 | |
| Interaction | GCM1 interactions | 1.67e-04 | 68 | 6 | 2 | int:GCM1 | |
| Interaction | NUP35 interactions | 1.76e-04 | 424 | 6 | 3 | int:NUP35 | |
| Interaction | GEMIN6 interactions | 1.87e-04 | 72 | 6 | 2 | int:GEMIN6 | |
| Interaction | SNRPC interactions | 1.97e-04 | 440 | 6 | 3 | int:SNRPC | |
| Interaction | SMAD3 interactions | 2.06e-04 | 447 | 6 | 3 | int:SMAD3 | |
| Interaction | TRIM31 interactions | 2.16e-04 | 454 | 6 | 3 | int:TRIM31 | |
| Interaction | IRF1 interactions | 2.49e-04 | 83 | 6 | 2 | int:IRF1 | |
| Interaction | IRF4 interactions | 2.61e-04 | 85 | 6 | 2 | int:IRF4 | |
| Interaction | BRD3 interactions | 2.77e-04 | 494 | 6 | 3 | int:BRD3 | |
| Interaction | FOXI1 interactions | 3.06e-04 | 92 | 6 | 2 | int:FOXI1 | |
| Interaction | EP300 interactions | 3.11e-04 | 1401 | 6 | 4 | int:EP300 | |
| Interaction | SOX17 interactions | 3.26e-04 | 95 | 6 | 2 | int:SOX17 | |
| Interaction | PAX8 interactions | 4.45e-04 | 111 | 6 | 2 | int:PAX8 | |
| Interaction | TBR1 interactions | 4.61e-04 | 113 | 6 | 2 | int:TBR1 | |
| Interaction | H3-3B interactions | 4.69e-04 | 114 | 6 | 2 | int:H3-3B | |
| Interaction | CUL2 interactions | 4.70e-04 | 591 | 6 | 3 | int:CUL2 | |
| Interaction | CREBBP interactions | 4.89e-04 | 599 | 6 | 3 | int:CREBBP | |
| Interaction | BRD7 interactions | 5.85e-04 | 637 | 6 | 3 | int:BRD7 | |
| Interaction | NAF1 interactions | 6.86e-04 | 138 | 6 | 2 | int:NAF1 | |
| Interaction | FUS interactions | 9.70e-04 | 757 | 6 | 3 | int:FUS | |
| Interaction | CSTF2 interactions | 9.78e-04 | 165 | 6 | 2 | int:CSTF2 | |
| Interaction | EGR2 interactions | 1.05e-03 | 171 | 6 | 2 | int:EGR2 | |
| Interaction | LHX2 interactions | 1.20e-03 | 183 | 6 | 2 | int:LHX2 | |
| Interaction | LHX3 interactions | 1.23e-03 | 185 | 6 | 2 | int:LHX3 | |
| Interaction | KLF5 interactions | 1.36e-03 | 195 | 6 | 2 | int:KLF5 | |
| Interaction | GATA2 interactions | 1.42e-03 | 199 | 6 | 2 | int:GATA2 | |
| Interaction | FEV interactions | 1.47e-03 | 203 | 6 | 2 | int:FEV | |
| Interaction | USP54 interactions | 1.61e-03 | 212 | 6 | 2 | int:USP54 | |
| Interaction | THOC2 interactions | 1.71e-03 | 219 | 6 | 2 | int:THOC2 | |
| Interaction | RARA interactions | 1.78e-03 | 223 | 6 | 2 | int:RARA | |
| Interaction | BAG4 interactions | 1.79e-03 | 224 | 6 | 2 | int:BAG4 | |
| Interaction | KLF3 interactions | 1.86e-03 | 228 | 6 | 2 | int:KLF3 | |
| Interaction | NR3C1 interactions | 2.02e-03 | 974 | 6 | 3 | int:NR3C1 | |
| Interaction | SMAD1 interactions | 2.10e-03 | 243 | 6 | 2 | int:SMAD1 | |
| Interaction | CHEK1 interactions | 2.14e-03 | 245 | 6 | 2 | int:CHEK1 | |
| Interaction | HDAC1 interactions | 2.92e-03 | 1108 | 6 | 3 | int:HDAC1 | |
| Interaction | PHB1 interactions | 3.04e-03 | 1123 | 6 | 3 | int:PHB1 | |
| Interaction | MBD3 interactions | 3.08e-03 | 295 | 6 | 2 | int:MBD3 | |
| Interaction | RUNX1 interactions | 3.70e-03 | 324 | 6 | 2 | int:RUNX1 | |
| Interaction | BCLAF1 interactions | 3.77e-03 | 327 | 6 | 2 | int:BCLAF1 | |
| Interaction | BRCA1 interactions | 4.12e-03 | 1249 | 6 | 3 | int:BRCA1 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 8.61e-06 | 200 | 6 | 3 | M5991 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 3.61e-05 | 323 | 6 | 3 | M9150 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.01e-04 | 457 | 6 | 3 | M1613 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.10e-04 | 470 | 6 | 3 | MM1053 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP | 8.26e-04 | 197 | 6 | 2 | M6125 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN | 8.35e-04 | 198 | 6 | 2 | M6033 | |
| Coexpression | GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP | 8.43e-04 | 199 | 6 | 2 | M9027 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 8.43e-04 | 199 | 6 | 2 | M9498 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 8.43e-04 | 199 | 6 | 2 | M7374 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 8.43e-04 | 199 | 6 | 2 | M6194 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP | 8.43e-04 | 199 | 6 | 2 | M8769 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 8.43e-04 | 199 | 6 | 2 | M5620 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 8.43e-04 | 199 | 6 | 2 | M5406 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN | 8.52e-04 | 200 | 6 | 2 | M8297 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 8.52e-04 | 200 | 6 | 2 | M8050 | |
| Coexpression | GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP | 8.52e-04 | 200 | 6 | 2 | M8068 | |
| Coexpression | GSE27786_NKCELL_VS_ERYTHROBLAST_UP | 8.52e-04 | 200 | 6 | 2 | M4853 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_UP | 8.52e-04 | 200 | 6 | 2 | M5367 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 8.52e-04 | 200 | 6 | 2 | M8765 | |
| Coexpression | GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN | 8.52e-04 | 200 | 6 | 2 | M3320 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 1.50e-03 | 1144 | 6 | 3 | MM3843 | |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | 1.76e-03 | 289 | 6 | 2 | M13630 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 1.83e-03 | 294 | 6 | 2 | M40873 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 2.10e-03 | 316 | 6 | 2 | M2248 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 2.16e-03 | 320 | 6 | 2 | MM1063 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.52e-04 | 186 | 6 | 2 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.52e-04 | 186 | 6 | 2 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-04 | 191 | 6 | 2 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| Computational | Neighborhood of UBE2N | 5.59e-05 | 154 | 6 | 3 | GCM_UBE2N | |
| Computational | Neighborhood of MYST2 | 7.77e-05 | 172 | 6 | 3 | GCM_MYST2 | |
| Computational | Neighborhood of ZNF198 | 1.71e-03 | 117 | 6 | 2 | GCM_ZNF198 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.93e-06 | 176 | 6 | 3 | 7499_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.25e-05 | 197 | 6 | 3 | 5292_DN | |
| Drug | 2d41 | 2.03e-05 | 27 | 6 | 2 | CID009543496 | |
| Drug | 1,1,1-trichloroethane | 1.23e-04 | 66 | 6 | 2 | ctd:C024566 | |
| Drug | stannous fluoride | 1.23e-04 | 66 | 6 | 2 | CID000024550 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.50e-04 | 163 | 6 | 2 | 5594_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.68e-04 | 165 | 6 | 2 | 6085_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.68e-04 | 165 | 6 | 2 | 2835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.77e-04 | 166 | 6 | 2 | 2247_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 7.87e-04 | 167 | 6 | 2 | 5217_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.96e-04 | 168 | 6 | 2 | 3868_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.06e-04 | 169 | 6 | 2 | 6064_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.06e-04 | 169 | 6 | 2 | 5231_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.06e-04 | 169 | 6 | 2 | 5572_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.15e-04 | 170 | 6 | 2 | 5417_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.15e-04 | 170 | 6 | 2 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.25e-04 | 171 | 6 | 2 | 5441_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.34e-04 | 172 | 6 | 2 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.34e-04 | 172 | 6 | 2 | 7179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.34e-04 | 172 | 6 | 2 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.34e-04 | 172 | 6 | 2 | 4112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.44e-04 | 173 | 6 | 2 | 3243_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.44e-04 | 173 | 6 | 2 | 4237_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.54e-04 | 174 | 6 | 2 | 6579_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.54e-04 | 174 | 6 | 2 | 3462_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.54e-04 | 174 | 6 | 2 | 5693_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 8.54e-04 | 174 | 6 | 2 | 5580_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.54e-04 | 174 | 6 | 2 | 1659_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.54e-04 | 174 | 6 | 2 | 5065_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.63e-04 | 175 | 6 | 2 | 6891_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.73e-04 | 176 | 6 | 2 | 5976_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.73e-04 | 176 | 6 | 2 | 6932_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 8.73e-04 | 176 | 6 | 2 | 6980_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.73e-04 | 176 | 6 | 2 | 6784_DN | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 8.73e-04 | 176 | 6 | 2 | 6179_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.83e-04 | 177 | 6 | 2 | 6434_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 8.83e-04 | 177 | 6 | 2 | 1645_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.83e-04 | 177 | 6 | 2 | 5308_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 8.83e-04 | 177 | 6 | 2 | 6551_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.93e-04 | 178 | 6 | 2 | 4184_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 8.93e-04 | 178 | 6 | 2 | 6193_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.93e-04 | 178 | 6 | 2 | 1672_DN | |
| Drug | fisetin; Down 200; 50uM; PC3; HG-U133A | 8.93e-04 | 178 | 6 | 2 | 579_DN | |
| Drug | scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A | 9.03e-04 | 179 | 6 | 2 | 6901_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 9.03e-04 | 179 | 6 | 2 | 331_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.03e-04 | 179 | 6 | 2 | 5484_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.13e-04 | 180 | 6 | 2 | 5511_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.13e-04 | 180 | 6 | 2 | 4541_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.13e-04 | 180 | 6 | 2 | 4821_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.23e-04 | 181 | 6 | 2 | 3643_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 9.23e-04 | 181 | 6 | 2 | 6951_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 9.54e-04 | 184 | 6 | 2 | 6939_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 9.74e-04 | 186 | 6 | 2 | 5010_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.01e-03 | 189 | 6 | 2 | 6793_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 7439_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 3144_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 1636_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 4362_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 5362_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 2866_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.03e-03 | 191 | 6 | 2 | 1227_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.03e-03 | 191 | 6 | 2 | 4299_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A | 1.04e-03 | 192 | 6 | 2 | 4334_DN | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 1.04e-03 | 192 | 6 | 2 | 3245_DN | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 1.04e-03 | 192 | 6 | 2 | 2722_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 1.04e-03 | 192 | 6 | 2 | 1647_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.04e-03 | 192 | 6 | 2 | 4816_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 3672_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 6749_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 1644_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 6751_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 5232_DN | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 6587_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 3434_UP | |
| Drug | trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A | 1.05e-03 | 193 | 6 | 2 | 413_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 6646_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 7538_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; HL60; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 1274_UP | |
| Drug | F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 6424_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 2655_DN | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 4848_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 2293_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 5017_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 4602_DN | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 5049_DN | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 2792_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 3212_UP | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 6330_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.07e-03 | 195 | 6 | 2 | 1053_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 5327_DN | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 6129_DN | |
| Disease | Malignant neoplasm of breast | 8.86e-04 | 1074 | 6 | 3 | C0006142 | |
| Disease | Colorectal Neoplasms | 1.28e-03 | 277 | 6 | 2 | C0009404 | |
| Disease | testosterone measurement | 1.46e-03 | 1275 | 6 | 3 | EFO_0004908 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.63e-03 | 312 | 6 | 2 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.66e-03 | 315 | 6 | 2 | EFO_0004574, EFO_0004612 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.72e-03 | 321 | 6 | 2 | EFO_0004612, EFO_0004639 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.82e-03 | 330 | 6 | 2 | EFO_0004529, EFO_0004612 | |
| Disease | free androgen index | 2.32e-03 | 374 | 6 | 2 | EFO_0007005 | |
| Disease | neutrophil percentage of leukocytes | 6.06e-03 | 610 | 6 | 2 | EFO_0007990 | |
| Disease | uric acid measurement | 6.06e-03 | 610 | 6 | 2 | EFO_0004761 | |
| Disease | hair colour measurement | 6.15e-03 | 615 | 6 | 2 | EFO_0007822 | |
| Disease | lymphocyte percentage of leukocytes | 7.16e-03 | 665 | 6 | 2 | EFO_0007993 | |
| Disease | Colorectal Carcinoma | 7.96e-03 | 702 | 6 | 2 | C0009402 | |
| Disease | monocyte percentage of leukocytes | 8.60e-03 | 731 | 6 | 2 | EFO_0007989 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQQYGHYGYNQRPPY | 101 | Q9BTL3 | |
| GQYGPQGGYPRQPNY | 801 | O14497 | |
| YGQQSSYPGYGQQPA | 91 | P35637 | |
| APSQYPGYQQGQGQQ | 351 | O75177 | |
| PGYQQGQGQQYGSYR | 356 | O75177 | |
| QRPYGYEQGQYGNYQ | 381 | O75177 | |
| QYPGQQGYPGQQQGY | 351 | Q15532 | |
| YPNYPQGQGQQYGGY | 376 | Q15532 | |
| QGQGQQYGGYRPTQP | 381 | Q15532 | |
| PQQRPYGYDQGQYGN | 401 | Q15532 | |
| PNYGNQQYGPNSQFP | 411 | Q9ULJ6 |